It's Pink October! These Innovative Companies Are Championing Women's Health in Biotech, Diagnostics, and More

“Pink October” is globally known for raising awareness about breast cancer (October is Breast Cancer Awareness Month) and World Menopause Day falls on October 18th.

But the conversation around women’s health deserves to stretch further: into menopause, diagnostics, precision care, and supportive therapies.

At Sosna + Co, we bring a women-led team mindset to this space, and have already partnered with life science companies commercializing women’s health assets.

This month, we’re spotlighting that innovation and offering our business development expertise to propel your growth globally.

Want to connect? Book a 30-minute strategy call.

Why Women’s Health Is Ripe for Strategic BD

  • Under-invested & high unmet need: Many women’s health conditions, like menopausal symptoms, menstrual disorders, or hormone-driven diseases, have lagged in R&D and commercialization funding.

  • Regulatory & reimbursement tailwinds: Agencies are increasingly open to solutions in women’s health, especially non-hormonal, safer, or cost-effective alternatives (though speed and priority remain an issue in many regions).

  • Global markets with diverse gaps: From Latin America to MENA to Southeast Asia, there’s demand for diagnostics, therapeutics, and platforms designed for regional needs.

  • A values-aligned space: As mentioned, Sosna + Co is women owned and led, with a 100% female team! This gives us aligned purpose and an authentic desire to represent women’s health companies.

Innovative Women’s Health Companies to Watch

These are the types of companies doing the frontier work we believe in, and the kinds of companies we partner with to support BD, licensing, and market expansion.

MeyVida

This company is pioneering the 28 Days™ at-home diagnostic platform, which tracks hormonal, metabolic, and symptom data across a full cycle, not just a single snapshot. It’s a powerful tool for understanding transitions like perimenopause and improving personalization in women’s health care. MeyVida - A Better Life+1

EndoCyclic Therapeutics

Developing ENDO-205 (a non-hormonal, disease-modifying therapy for endometriosis) and ENDO-210 (a diagnostic agent) for gynecological disease. SEED

Aspira Women’s Health

Working on ENDOinform™, an AI-enabled blood test to noninvasively diagnose endometriosis, avoiding surgery. We Will Cure

AOA Dx


AOA Dx is building an AI-enabled early cancer detection platform focused on women’s health, using multi-omics and lipidomics biomarkers. Its GlycoLocate™ technology aims to provide noninvasive diagnostics for ovarian and breast cancers. AOA DX

Hera Biotech

Hera develops noninvasive diagnostic tools for endometriosis and cervical disease. Their AI-powered platform supports disease staging and point-of-care diagnostics, offering better clarity in a field often burdened by delayed diagnoses. Hera Biotech

Renovia

Renovia is a Boston-based medtech company specializing in diagnostic and therapeutic devices for pelvic floor disorders. Their innovations aim to improve care in an area often underserved in women’s health. Seedtable

NextGen Jane

NextGen Jane has developed a “smart tampon” system to sample biomarkers from menstrual fluid, providing insight into reproductive health and potentially detecting gynecological conditions like cervical disease or endometriosis. Wikipedia

Allara Health

Allara takes a holistic women’s health approach—diagnosing and treating conditions like PCOS, endometriosis, thyroid disorders, menopause, and more via an integrated care model. Their platform blends diagnostics and care delivery. Allara Health

How Sosna + Co Supports Women’s Health Companies

As a boutique life science business development firm, we're the outsourced solution for pipeline growth, licensing and strategic partnerships, M&A advisory, and lead generation.

A snapshot of how we can support you:

  1. Tailored Targeting
    Through our network of 130,000 activated contacts, we build tiered, region-specific partner lists (e.g., diagnostic firms, specialty pharma, global health orgs, distributors) filtered for the right modality, geography, and fit.

  2. Strategic Campaign Design
    From non-confidential overviews and whitepapers to internal tracking, we design campaigns that speak both to the science and the addressable market.

  3. Multichannel Execution
    We run outreach via warm intros to our network (20 years in the making), conference engagements (you can find us at the top life science events globally), digital channels, and secure diligence processes (NDAs, RFIs, etc.).

  4. Deal Facilitation & Closing
    We actively manage negotiation, term structuring, and follow-up until the agreement is signed—ensuring momentum doesn’t stall.

Because of our women-led identity and deep network, we understand the stakes, the sensitivities, and the untapped opportunities in this field.

Conclusions & Next Steps

If you’re developing a diagnostic, therapeutic, or platform in women’s health—whether breast cancer, menopause, reproductive care, or beyond—let’s talk.


We’d love to explore how Sosna + Co can accelerate your BD, licensing, and global partnerships. Submit an inquiry, or book a meeting with our team.

life science, businessErica Sosnowski